Supernus Pharmaceuticals (NASDAQ:SUPN)

CAPS Rating: 5 out of 5 81.48

Caps

How do you think SUPN will perform against the market?

Add Stock to CAPS Watchlist

All Players

68 Outperform
11 Underperform
 

All-Star Players

19 Outperform
3 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top SUPN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

crashavoidance (99.81)
Submitted July 29, 2015

Already done well with this but believe still some good upside if the two drugs still in development pan out (so far looks good but longer term / higher risk play until actually happens)In the meantime, approach of adding ER (extended release) to… More

TMFBlacknGold (93.33)
Submitted June 29, 2012

Man, I wish I got in on this one just a few days earlier (IPO debut). Still, this is about as safe as a red thumb gets. Supernus has shareholders' equity of just $270,000 as of 1Q12, which registers as a fair book value of a whopping $0.0113 per… More

SUPN VS S&P 500 (SPY)

Fools bullish on SUPN are also bullish on:

Fools bearish on SUPN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SUPN.

Recs

0
Member Avatar genedom (92.67) Submitted: 3/14/2019 3:27:37 PM : Outperform Start Price: $37.71 SUPN Score: +0.44

Good value at 38. Fair value should be 44-50. 4th P3 trial will be positive.

Recs

0
Member Avatar 1russianguy (89.83) Submitted: 8/14/2018 12:02:18 PM : Outperform Start Price: $42.40 SUPN Score: -9.82

Strong growth.

Recs

0
Member Avatar BrerBear (54.85) Submitted: 5/27/2018 6:22:43 PM : Outperform Start Price: $50.95 SUPN Score: -28.95

Best in class pharma for treatment of central nervous system diseases

Leaderboard

Find the members with the highest scoring picks in SUPN.

Score Leader

mstanphi

mstanphi (53.41) Score: +516.30

The Score Leader is the player with the highest score across all their picks in SUPN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mstanphi 53.41 6/14/2012 8/8/2013 Outperform 3Y $5.22 +628.35% +112.05% +516.30 0 Comment
ptanabe < 20 8/1/2013 Outperform 5Y $6.87 +453.42% +66.13% +387.29 1 Comment
MichaelHamilton 98.64 8/20/2013 Outperform 5Y $6.95 +447.05% +71.11% +375.94 0 Comment
Kilroy9376 91.85 1/22/2013 Outperform 5Y $7.35 +417.28% +90.39% +326.89 0 Comment
crashavoidance 99.81 1/13/2014 Outperform 5Y $8.03 +373.47% +55.62% +317.86 1 Comment
davisbunn < 20 9/17/2014 Outperform 3Y $8.40 +352.62% +40.97% +311.65 0 Comment
SweetT 38.50 1/6/2014 Outperform 5Y $8.19 +364.22% +53.92% +310.30 0 Comment
KidJones 31.31 3/11/2013 Outperform 5Y $7.81 +386.81% +81.81% +305.00 0 Comment
wilburn1121 < 20 1/12/2015 Outperform 1Y $8.74 +335.01% +38.15% +296.86 0 Comment
mirqce < 20 11/24/2014 Outperform NS $8.94 +325.28% +36.31% +288.97 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJanney 85.14 12/4/2017 Outperform NS $38.85 -2.14% +6.04% -8.18 0 Comment
TrackPiperJaff 85.60 6/1/2017 Outperform NS $38.30 -0.73% +16.71% -17.44 0 Comment
TrackLazardCapit 75.71 12/5/2012 Outperform NS $8.15 +366.50% +99.76% +266.74 0 Comment

Advertisement